Found 23 results in Expert Content

This case study highlights Catalent’s advanced fiber-optic micro-dissolution technology developed at its Nottingham site to overcome limitations of traditional HPLC-based dissolution testing.

This case study highlights Catalent Nottingham’s development of a helium-free gas chromatography (GC) solution using nitrogen as an alternative carrier gas.

ASAPprime® predictive modeling has been integrated into our stability testing workflows to help customers make faster, more informed decisions during oral solid dose development.

Summary: Download this fact sheet to learn more about our experience and expertise with nitrosamines testing.

Summary: Download this article to learn more about the current regulatory expectations for E&L, elemental impurities and nitrosamines testing, as well as the latest advances in analytical methods.

Summary: Explore Catalent’s extensive standalone analytical services with industry leading equipment and network of over 3,000 scientists. Learn how our deep expertise supporting pharmaceuticals, biologics (protein, cell and therapy, and vaccines), inhalation (nasal and dry powder inhaler), drug product/substance and in-process samples could help accelerate your drug product's journey.

Summary: In this webinar, experts will explore E&L, impurities, and nitrosamines testing regulations, methods, and accelerated pharmaceutical testing.

Summary: Catalent specializes in small molecule solid-state characterization, leveraging a vast network of scientists for successful drug candidate development by choosing the best API form.

Summary: Catalent has supported drug development since 1991, focusing on E&L. They use well-characterized materials to ensure drug product safety and quality.

Comparing the dissolution rates and pellet structure of branded Sporanox® with three similar generic products, raman spectroscopy revealed recrystallizing API slowed the dissolution rate.